Adaptive Biotechnologies(US:ADPT)2026-02-05 21:15Financial Results - Adaptive Biotechnologies Corporation reported financial results for the quarter and year ended December 31, 2025[4]. - The press release detailing the financial results was issued on January 12, 2026[4]. - The financial results include key metrics that will be detailed in the attached press release and presentation[4][6]. - The report does not include specific performance metrics or guidance in the provided content[4][6]. Investor Relations - The company provided an Investor Presentation intended for meetings with investors and analysts[6]. - The company has not indicated any obligation to update the Investor Presentation in the future[6]. Company Information - The company is not classified as an emerging growth company under the relevant regulations[3]. - The company is based in Seattle, Washington, and trades on the NASDAQ under the symbol ADPT[2]. Report Details - The financial statements and exhibits related to the report are included as attachments[9]. - The report was signed by Kyle Piskel, Chief Financial Officer, on January 12, 2026[13].